SITC 2022 | Identifying and managing patients who develop ICI-associated acute kidney injury

Shruti Gupta, MD, Brigham and Women’s Hospital, Boston, MA, talks on the significance of nephrologists and oncologists collaborating to identify and manage patients who develop immune checkpoint inhibitor-associated acute kidney injury (ICPi-AKI). This interview took place at the 37th Annual Meeting of the Society for Immunotherapy in Cancer (SITC 2022) in Boston, MA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.